Hospital Profile
Name | Bayonne Medical Center |
---|
Type | Acute Care Hospital |
---|
Location | 29 East 29th St, Bayonne, New Jersey |
---|
Ownership | Voluntary non-profit - Private |
---|
Emergency Services | Yes |
---|
Medicare ID (CCN) | 310025 |
Patients' Experience Survey:
Overall Rating of the Hospital:
Willingness to Recommend Hospital:
Yes Patients who reported YES, they would definitely recommend the hospital
Probably Patients who reported YES, they would probably recommend the hospital
No Patients who reported NO, they would probably not or definitely not recommend the hospital
Cleanliness of Hospital Environment:
Always Patients who reported that their room and bathroom were "Always" clean
Usually Patients who reported that their room and bathroom were "Usually" clean
Sometimes or Never Patients who reported that their room and bathroom were "Sometimes" or "Never" clean
Quietness of Hospital Environment:
Always Patients who reported that the area around their room was "Always" quiet at night
Usually Patients who reported that the area around their room was "Usually" quiet at night
Sometimes or Never Patients who reported that the area around their room was "Sometimes" or "Never" quiet at night
Always Patients who reported that their nurses "Always" communicated well
Usually Patients who reported that their nurses "Usually" communicated well
Sometimes or Never Patients who reported that their nurses "Sometimes" or "Never" communicated well
Always Patients who reported that their doctors "Always" communicated well
Usually Patients who reported that their doctors "Usually" communicated well
Sometimes or Never Patients who reported that their doctors "Sometimes" or "Never" communicated well
Responsiveness of Hospital Staff:
Always Patients who reported that they "Always" received help as soon as they wanted
Usually Patients who reported that they "Usually" received help as soon as they wanted
Sometimes or Never Patients who reported that they "Sometimes" or "Never" received help as soon as they wanted
Communication about Medicines:
Always Patients who reported that staff "Always" explained about medicines before giving it to them
Usually Patients who reported that staff "Usually" explained about medicines before giving it to them
Sometimes or Never Patients who reported that staff "Sometimes" or "Never" explained about medicines before giving it to them
Yes Patients who reported that YES, they were given information about what to do during their recovery at home
No Patients who reported that NO, they were not given information about what to do during their recovery at home
Always Patients who "Strongly Agree" they understood their care when they left the hospital
Usually Patients who “Agree” they understood their care when they left the hospital
Sometimes or Never Patients who “Disagree” or “Strongly Disagree” they understood their care when they left the hospital
NPI Associated with the Hospital:
Unlike individual providers, Hospitals may have multiple NPI numbers for example, there can be a separate NPI for each unit within the hospital. We have found possible NPI number/s associated with Bayonne Medical Center from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.
NPI Number | 1437356755 |
Organization Name | IJKG OPCO LLC |
Doing Business As | BAYONNE MEDICAL CENTER |
Address | 29th Street At Avenue E, Bayonne, NJ 07002 |
Hospital Type | General Acute Care Hospital |
Phone Number | 201-858-5000 |
News Archive
At some California hospitals, fewer than half of workers get the flu shot
How well are doctors, nurses and other workers at your local hospital vaccinated against the flu?
Anacor, Medicis collaborate to discover and develop boron-based treatment for acne
Anacor Pharmaceuticals, Inc. and Medicis Pharmaceutical Corporation today announced that the two companies have entered into a research and development agreement to discover and develop boron-based small molecule compounds directed against a target for the potential treatment of acne.
IONTAS wins 'Small Business of the Year' category at Cambridge News Business Excellence Awards 2019
IONTAS Limited, a leader in the discovery and optimization of fully human antibodies, has won ‘Small Business of the Year' category at the Cambridge News Business Excellence Awards 2019.
FDA approves first oral medication for treatment of adults with Fabry disease
The U.S. Food and Drug Administration today approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease.
Read more Medical News
› Verified 9 days ago
NPI Number | 1750717914 |
Organization Name | BAYONNE MEDICAL CENTER |
Address | 29 East 29th Street, Ave. E, Bayonne, NJ 07002 |
Hospital Type | General Acute Care Hospital |
Phone Number | 201-858-5000 |
News Archive
At some California hospitals, fewer than half of workers get the flu shot
How well are doctors, nurses and other workers at your local hospital vaccinated against the flu?
Anacor, Medicis collaborate to discover and develop boron-based treatment for acne
Anacor Pharmaceuticals, Inc. and Medicis Pharmaceutical Corporation today announced that the two companies have entered into a research and development agreement to discover and develop boron-based small molecule compounds directed against a target for the potential treatment of acne.
IONTAS wins 'Small Business of the Year' category at Cambridge News Business Excellence Awards 2019
IONTAS Limited, a leader in the discovery and optimization of fully human antibodies, has won ‘Small Business of the Year' category at the Cambridge News Business Excellence Awards 2019.
FDA approves first oral medication for treatment of adults with Fabry disease
The U.S. Food and Drug Administration today approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease.
Read more Medical News
› Verified 9 days ago
NPI Number | 1821101239 |
Organization Name | IJKG OPCO LLC |
Doing Business As | BAYONNE MEDICAL CENTER |
Address | 29th St At Ave E, Bayonne, NJ 07002 |
Hospital Type | General Acute Care Hospital |
Phone Number | 201-858-5000 |
News Archive
At some California hospitals, fewer than half of workers get the flu shot
How well are doctors, nurses and other workers at your local hospital vaccinated against the flu?
Anacor, Medicis collaborate to discover and develop boron-based treatment for acne
Anacor Pharmaceuticals, Inc. and Medicis Pharmaceutical Corporation today announced that the two companies have entered into a research and development agreement to discover and develop boron-based small molecule compounds directed against a target for the potential treatment of acne.
IONTAS wins 'Small Business of the Year' category at Cambridge News Business Excellence Awards 2019
IONTAS Limited, a leader in the discovery and optimization of fully human antibodies, has won ‘Small Business of the Year' category at the Cambridge News Business Excellence Awards 2019.
FDA approves first oral medication for treatment of adults with Fabry disease
The U.S. Food and Drug Administration today approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease.
Read more Medical News
› Verified 9 days ago
Structural Quality Measures:
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
At some California hospitals, fewer than half of workers get the flu shot
How well are doctors, nurses and other workers at your local hospital vaccinated against the flu?
Anacor, Medicis collaborate to discover and develop boron-based treatment for acne
Anacor Pharmaceuticals, Inc. and Medicis Pharmaceutical Corporation today announced that the two companies have entered into a research and development agreement to discover and develop boron-based small molecule compounds directed against a target for the potential treatment of acne.
IONTAS wins 'Small Business of the Year' category at Cambridge News Business Excellence Awards 2019
IONTAS Limited, a leader in the discovery and optimization of fully human antibodies, has won ‘Small Business of the Year' category at the Cambridge News Business Excellence Awards 2019.
FDA approves first oral medication for treatment of adults with Fabry disease
The U.S. Food and Drug Administration today approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease.
Read more News
› Verified 9 days ago